10x Genomics, Inc.
TXG
$11.17
-$0.53-4.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.28% | 6.56% | 11.14% | 16.64% | 19.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.28% | 6.56% | 11.14% | 16.64% | 19.81% |
| Cost of Revenue | -6.40% | 18.22% | 48.65% | 69.58% | 74.39% |
| Gross Profit | 1.34% | 1.54% | -2.31% | -0.38% | 3.28% |
| SG&A Expenses | -0.02% | 2.28% | 5.36% | 10.34% | 16.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.86% | 3.91% | 10.84% | 17.23% | 20.33% |
| Operating Income | 3.64% | 4.56% | -9.85% | -19.05% | -21.98% |
| Income Before Tax | 28.57% | 19.52% | -39.77% | -51.19% | -53.58% |
| Income Tax Expenses | -22.24% | 38.59% | 20.97% | 67.82% | 57.26% |
| Earnings from Continuing Operations | 28.41% | 18.27% | -39.17% | -51.61% | -53.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.41% | 18.27% | -39.17% | -51.61% | -53.67% |
| EBIT | 3.64% | 4.56% | -9.85% | -19.05% | -21.98% |
| EBITDA | 4.65% | 8.49% | -6.13% | -13.88% | -18.68% |
| EPS Basic | 30.30% | 20.21% | -35.51% | -46.98% | -49.05% |
| Normalized Basic EPS | 5.09% | 11.02% | -2.37% | -10.80% | -10.68% |
| EPS Diluted | 30.30% | 20.21% | -35.51% | -46.98% | -49.05% |
| Normalized Diluted EPS | 5.09% | 11.02% | -2.37% | -10.80% | -10.68% |
| Average Basic Shares Outstanding | 2.81% | 3.00% | 3.16% | 3.13% | 2.90% |
| Average Diluted Shares Outstanding | 2.81% | 3.00% | 3.16% | 3.13% | 2.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
